Bruce E. Taillon

Dr. Bruce Taillon is a recognized leader in the biopharmaceutical space with more than two decades of experience in research and development, including infectious and inflammatory disease and oncology, across diverse animal species. Taillon leads Codagenix’s Animal Health portfolio, developing vaccines to keep livestock and companion animals healthy. Prior to joining Codagenix, Taillon served as Senior Director of External Innovation & Business Development of Elanco Animal Health; Global Head, Business & Product Development, at Enzo Life Sciences; and Director of Technology & Health Care Business Development at 454 Life Sciences, a Roche Company. Dr. Taillon has a B.S. in Biology from the University of South Carolina and a Ph.D. in Biological Sciences from Carnegie Mellon University.